Want to join the conversation?
Medical technology company $INGN posted 4Q15 net income of $3.9MM, up 154% vs. $1.5MM in 4Q14, helped by strong revenue, improved GM, and a lower effective tax rate. Diluted EPS for the quarter was $0.19 vs. $0.07 in 4Q14. Total revenue rose 38.9% to $40.4MM vs. $29.1MM in 4Q14, helped by higher sales and rental revenues.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)